1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsCF Research Innovation Awards is sponsored by Vertex Pharmaceuticals. Provides substantial multi-year funding for innovative research in cystic fibrosis.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Investigator Sponsored Studies by Vertex Pharmaceuticals | Atom Grants Investigator Sponsored Studies Vertex ISS grants fund investigator-led research advancing science and patient care in cystic fibrosis, sickle cell disease, beta thalassemia, IgA nephropathy, and pain.
Funder: Vertex Pharmaceuticals Due Dates: Rolling (CF, Pain, IgA Nephropathy) | RFP-based (Beta Thalassemia, Sickle Cell Disease; currently closed) Funding Amounts: No preset cap; budgets must represent fair market value and generally not exceed 35% institutional overhead.
Summary: Supports independent, investigator-led research advancing scientific knowledge in areas aligned with Vertex’s interests, including cystic fibrosis, sickle cell disease, IgA nephropathy, and pain. Key Information: Funding is not available for retrospective/ongoing work, FTE-based personnel costs, or travel.
Vertex Pharmaceuticals' Investigator Sponsored Studies (ISS) program provides funding for independent, investigator-initiated research that advances scientific understanding and patient care in disease areas of interest to Vertex. The program welcomes a range of clinical, observational, and nonclinical studies, particularly those exploring disease mechanisms, patient populations, and medical treatments relevant to Vertex’s portfolio.
Supported research areas include cystic fibrosis, sickle cell disease, beta thalassemia, IgA nephropathy, and pain (US only). The ISS program is designed to foster collaboration with leading researchers and clinicians who share Vertex’s commitment to improving outcomes for people living with serious diseases. See the full grant listing
According to the current listing, eligibility includes: Researchers and institutions conducting innovative CF research. Confirm the full requirements in the official notice before applying.
The current listing shows up to $750,000 over 3 years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
CF Research Innovation Awards is funded by Vertex Pharmaceuticals. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.